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Xestospongins: Potent Membrane
Permeable Blockers of the Inositol
1,4,5-Trisphosphate Receptor
Juliette Gafni,* Julia A. Munsch,² Tien H. Lam,* known (Brann et al., 1993; Arrang, 1994; Pin and Duvoi-
Michelle C. Catlin,³ Lucio G. Costa,³ sin, 1995), chemical probes that selectively target the
Tadeusz F. Molinski,² and Isaac N. Pessah*§ IP3R are currently limited to heparin and IP3R antibodies.
*Department of Molecular Biosciences The usefulnessof heparin is limited due to its low affinity,
School of Veterinary Medicine lack of selectivity, membrane impermeability, and tar-
and Graduate Program in Neurosciences geting of the IP3-binding site (Ghosh et al., 1988;
²Department of Chemistry Kobayashi et al., 1988). Evidence that heparin inhibits
University of California the synthesis of IP3 (Berridge, 1993), and stimulates ry-
Davis, California 95616 anodine-sensitive Ca21 release (Bezprozvanny et al.,
³Department of Environmental Health 1993) have further complicated interpretation of results
University of Washington aimed at understanding the role of the IP3R in cellular
Seattle, Washington 98195 processes. Three IP3R antibodies have been shown to
block IP3-induced Ca21 release. The 18A10 monoclonal
antibody binds to the proposed Ca21 channel region in
Summary the carboxy-terminus of the receptor protein (amino acid
residues 2736±2747), inhibiting IP3-induced Ca21 release
Xestospongins (Xe's) A, C, D, araguspongine B, and in cerebellar microsomes (Nakade et al., 1991). Two
demethylxestospongin B, a group of macrocyclic other IP3R inhibitory serums have been developed, onebis-1-oxaquinolizidines isolated from the Australian targeting the 420 residues within the ªcouplingº domain
sponge, Xestospongia species,are shown to be potent
(amino acid residues 1379±1798) and the other binding
blockers of IP3-mediated Ca21 release from endoplas- to the 95 residues near the C-terminus (amino acidmic reticulum vesicles of rabbit cerebellum. XeC
residues 2604±2698) (Sullivan et al., 1995). Both of theseblocks IP3-induced Ca21 release (IC50 5 358 nM) without antibodies block IP3-stimulated Ca21 release and nu-interacting with the IP3-binding site, suggesting a
clear envelope assembly in Xenopus egg extracts (Sulli-mechanism that is independent of the IP3 effector site.
van et al., 1995). The main disadvantage of IP3R inhibi-Analysis of Pheochormocytoma cells and primary
tory antibodies is that they are membrane impermeableastrocytes loaded with Ca21-sensitive dye reveals that
and thus require specialized techniques (i.e., injection,XeC selectively blocks bradykinin- and carbamylcho-
patching onto cells) and/or disruption of cellular integrityline-induced Ca21 efflux from endoplasmic reticulum
(i.e., patching or permeabilization of cells) to access thestores. Xe's represent a new class of potent, mem-
IP3R.brane permeable IP3 receptor blockers exhibiting a
Since a large number of biologically active com-high selectivity over ryanodine receptors. Xe's are a
pounds isolated from marine organisms have beenvaluable tool for investigating the structure and func-
shown to interact with cellular receptors (Crews et al.,tion of IP3 receptors and Ca21 signaling in neuronal
and nonneuronal cells. 1994), we screened 120 species of marine sponges for
IP3R inhibitory activity. We found one sponge, Xesto-
Introduction spongia species, to contain five potent blockers of
IP3-mediated Ca21 release (IC50S ranging from 358 nM
The phosphoinositide signaling cascade plays a promi- to 5.9 mM). Structure elucidation revealed the active
nent role in neuronal signaling. High levels of the inositol principles to be the bis-1-oxaquinolizidines xestospon-
1,4,5-trisphosphate receptor (IP3R) are expressed in the gin A (XeA), xestospongin C (XeC), xestospongin D
cerebellum, hippocampus, cerebralcortex, corpus stria- (XeD), araguspongine B (ArB), and demethylxestospon-
tum, and olfactory tubercule (Verma et al., 1990). Stimu- gin B (DMXeB). Interestingly, XeA, XeC, and XeD were
lation of the IP3R results in Ca21 mobilization from intra- isolated by Nakagawa et al. (1984) and recognized for
cellular stores, which in turn activates many cellular
their vasodilative activity.
processes, including neuromodulation, synaptic plastic-
In the present study, we demonstrate that XeA, XeC,ity, and sensory perception (Berridge, 1993). Stimulation
XeD, ArB, and DMXeB are potent blockers of IP3-of G protein±linked or tyrosine kinase±linked cell surface
induced Ca21 release from isolated cerebellar micro-receptors leads not only to production of IP3 and subse-
somes, and display a high selectivity over the skeletalquent Ca21 release from endoplasmic reticulum (ER)
isoform of the ryanodine receptor (type 1; Ry1R). Thestores, but also to coordinated activation of intracellular
most potent of these blockers, XeC, is a membraneenzymes such as protein kinase C, phosphatidylinositol
permeable blocker of IP3-mediated Ca21 release in intact3-OH kinase, and GTPase-activating protein.
cells. A simple model is presented that relates structuralIn order to define the importance of the IP3R in neu-
aspects of the xestospongin/araguspongine family ofronal processes, selective,membrane permeable block-
1-oxaquinolizidine alkaloids to their potency at the IP3R.ers of the IP3R are needed. Whereas selective antago-
XeC provides an ideal pharmacological tool for investi-nists of the large variety of cell surface receptors are
gating the structure of the IP3R, as well as IP3-mediated
Ca21 signaling in neuronal and nonneuronal cells.§To whom correspondence should be addressed.
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Figure 1. Bis-1-Oxaquinolizidines Isolated from Xestospongia Species Are Potent IP3R Blockers
(A) Xe and araguspongine structures were extracted and purified from the Australian sponge, Xestospongia species, and tested for their
ability to block IP3-induced Ca21 release from cerebellar microsomes.
(B) Inhibition of IP3-induced Ca21 release from actively loaded cerebellar microsomes was used to determine the potency of the Xe/araguspon-
gine congeners tested. The IC50 values for the five congeners ranged from 358 nM to 5.9 mM (see text for details). Data from each compound
are fit to a single site model, and curves for XeC, ArB, XeD, and XeA represent the average of two experiments performed on two different
cerebellar microsomal preparations. The DMXeB curve is an average of three experiments. The mean rate (6SD) of Ca21 release for control
was 7.0 6 2.0 nmol Ca21 s21 mg21 with 5 mM IP3.
Results and Discussion crude MeOH extracts from 120 species of sponges for
IP3R inhibitory activity. Five potent IP3R inhibitors were
then isolated from Xestospongia species, the onlySubcellular Calcium Transport
and Binding Studies sponge containing potent IP3R inhibitors, using the
mechanism-based assay (Figure 1A). The specificity ofIP3-induced Ca21 transport across actively loaded rabbit
cerebellar microsomes was initially used to screen 120 the assay for detecting IP3-mediated Ca21 changes was
Xestospongins: IP3R Channel Blockers
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Figure 2. XeC Blocks IP3-Induced Ca21 Re-
lease by a Mechanism Independent of the
IP3-Binding Site
(A) Raw traces showing XeC blocks IP3 (5
mM)-induced Ca21 release from cerebellar mi-
crosomes in a dose-dependent manner.
(B) The dose±response curve for XeC is fit to
a multisite model to illustrate the multiphasic
nature of inhibition, whereas XeC (1±10 mM)
does not affect the ability of [3H]IP3 (1 nM) to
bind to cerebellar microsomes (200 mg
protein).
(C) XeC is .30-fold less potent toward
blocking [3H]ryanodine binding and caffeine-
induced Ca21 release in skeletal SR. XeC
(0.1±10 mM) blocked [3H]ryanodine (1 nM)
binding and caffeine (20 mM)-induced Ca21
release to a much lesser extent in Ca21-
loaded skeletal vesicles (50 mg protein) en-
riched in Ry1R. The control rate (6SD) of caf-
feine-induced Ca21 release averaged 28.4 6
6.0 nmol Ca21 s21 mg21.
initially tested. IP3-induced Ca21 release was stereose- IC50 of 648 nM, since ArB was not purified to homogene-
ity (z75 mol % purity). The addition of a hydroxyl grouplective, since Ca21 efflux from cerebellar microsomes
occurred only following addition of the D- (not L-) IP3 to C9 of XeC (XeD) diminished the potency of the cis/
trans system and elevated the IC50 to 844 nM. Substitut-enantiomer. Heparin ($20 mM), a known IP3R inhibitor,
also blocked IP3-induced Ca21 release from cerebellar ing the cis-fused oxaquinolizidine of XeD for a trans-
fused oxaquinolizidine (DMXeB) reduced inhibition ofmicrosomes, further verifying that IP3-mediated Ca21
release was being selectively measured. In addition, sat- IP3-induced Ca21 release by nearly an order of magni-
tude, raising the IC50 to 5865 nM.urating concentrations (7.5±20 mM) of XeA, XeC, XeD,
ArB, or DMXeB did not alter the absorbance of antipyry- While the more potent Xe's (XeC, ArB, XeD) tended
to produce a multiphasic inhibition of IP3-induced Ca21lazo III or the Ca21 calibration of the dye, verifying that
Xe's did not interfere with the ability of antipyrylazo III release from cerebellar microsomes, equivalent concen-
trations of XeC had no effect on the specific binding ofto detect changes in extramicrosomal Ca21.
Inhibition curves for XeA, XeC, XeD, ArB, and DMXeB [3H]IP3 to the same membrane vesicles (Figures 2A and
2B). For example, 10 mM XeC did not produce a de-were obtained by measuring Ca21 transport in cerebellar
microsomes. For each compound, duplicate experi- crease in specific [3H]IP3 binding, even though 7.5 mM
of XeC completely blocked IP3-mediated Ca21 release,ments using two different cerebellar microsomal prepa-
rations were performed to construct the inhibition indicating a noncompetitive mechanism with respect to
the IP3-binding site. The apparent multiphasic nature ofcurves shown in Figure 1B. All Xe's blocked IP3-medi-
ated Ca21 release in a dose-dependent manner. XeC, Xe inhibition curves (Figure 2B [XeC]) could beexplained
by the existence of multiple IP3R isoforms in the micro-which contains one cis-fused and one trans-fused oxa-
quinolizidine, proved to be the most potent IP3R inhibitor somal preparations from whole cerebella, which may
have different affinities for Xe's. At least three isoformswith an IC50 of 358 nM. The cis/trans combination exhib-
ited superior inhibition of IP3-induced Ca21 release, of the IP3R have been identified and cloned (Furuichi et
al., 1989; Mignery et al., 1990; SuÈ dhof et al., 1991; Rosswhen compared to the trans/trans system in XeA, which
has a nearly 10-fold larger IC50 of 2535 nM. It is not et al., 1992; Maranto, 1994; Yamada et al., 1994; Harnick
et al., 1995), and there is evidence that the cerebellumclear whether the cis/trans system is truly a more potent
inhibitor than the cis/cis system in ArB, which has an contains more than one of these isoforms (Nakanishi
Neuron
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et al., 1991; Ross et al., 1992). [3H]Ryanodine binding relates to IP3R channel activity are thus far precluded
since ArB could not be purified to homogeneity, and thestudies and caffeine-mediated Ca21 transport assays
using rabbit skeletal sarcoplasmic reticulum (SR) prepa- structures of impurities remain to be elucidated. XeD
and DMXeB are 9-hydroxy derivatives of XeC and ArB,rations showed that XeC also dose dependently inter-
acts with the Ry1R (Figure 2C). XeC (10 mM) decreased respectively. Although addition of an axial OH group at
C9 in XeD does not increase the molecular cross section[3H]ryanodine binding by 22% and caffeine-induced
Ca21 release by 46%, indicating that XeC can interact (see below), the added polarity and/or introduction of
an H-bond donor decreases potency z2.4-fold. The 16-with the Ry1R, but in a significantly less potent manner.
The IC50 for blocking caffeine-induced Ca21 release with fold decrease in potency seen with DMXeB is likely to
be mainly due to the cis ring fusions and cis C2,9 substit-XeC was (greater than 30-fold its IC50 for blocking
IP3-mediated Ca21 release from the IP3R. Differences in uents in both heterobicycles, with a smaller contribution
from the OH group at C9. In this respect, the potentXe potency toward IP3R and Ry1R blockade may also
reflect variations in amino acid sequences, especially activity seen with the ArB fraction may be attributed to
a yet to be identified Xe. XeC has been shown by X-rayaround the putative pore-forming region (Furuichi et al.,
1989; Mignery et al., 1989, 1990; Takeshima et al., 1989). crystallography to have a long narrow rod-like shape,
and this feature is preserved in the calculated MM2The mechanism by which Xe's block IP3-induced Ca21
release could be the result of either: (1) block of the structure. The calculated van der Waals profile was de-
fined by a rectangle of width of 8.22 AÊ , height of 5.78Ca21 channel pore, or (2) an allosteric mechanism that
uncouples IP3 binding from Ca21 release. Although the AÊ , and molecular cross section of 47.6 AÊ 2. The molecular
cross section (AÊ 2) is defined here as the area of a rectan-present study does not discriminate between the two
possible mechanisms, the chemical structure of Xe's, a gular whose sides are the minimum van derWaals height
and width of the narrowest projection or profile of thelipophilic elongated core with two partially charged N
groups at either end, provide an ideal lipophilic/hydro- MM2 minimized structure. In this respect, the OH moiety
of XeD does not contribute to the molecular cross sec-philic moiety to fit into the IP3R channel pore. Tinker and
Williams (1995) used a series of monovalent and divalent tion (47.6 AÊ 2) and only produces a small (2.4-fold) de-
crease in receptor potency. A major structural conse-trimethylammonium derivatives, which bear structural
resemblance to Xe's, to define the length of the pore quence of stereochemical differences between the
alkaloids related to XeC is a significant change in molec-of Ry2R (cardiac isoform) reconstituted in bilayer lipid
membranes. Based on the relative potency for pore ular cross section. Inverting the configurations at both
the bridgehead nitrogen and C9 of the flexible cis, transblockade, they concluded a pore distance of 10.4 AÊ .
Interestingly, their estimate is consistent with the molec- C2,9 diequatorial (bent) configuration of XeC to the flat-
tened, more rigid trans, trans C2,9 diequatorial configu-ular distance between thepartially charged tertiarynitro-
gens of XeC (11.6 AÊ ). Despite the very similar molecular ration of XeA widens the molecule in order to accommo-
date bowing of the methylene chains between the twostructures of Xe's, some useful empirical correlations
can bedrawn regarding how structure relates to potency oxaquinolizidine moieties and reduces potency more
significantly (7-fold). The van der Waals profile changestoward inhibition of IP3-induced Ca21 release. Two im-
portant considerations in this respect are net charge accordingly to a width of 9.38 AÊ , a height of 5.34 AÊ , and
an overall larger molecular cross section (49.8 AÊ 2). Thus,and molecular dimensions. The free bases of Xe are
relatively lipophilic molecules and readily soluble in the molecular dimensions of Xe's appear to be more
important in defining potency for IP3R channel blockadechloroform or methanol. The bridgehead nitrogen of the
oxaquinolizidine ring system is moderately basic having than the presence of an OH at C9, although the presence
of the latter disrupts some yet undefined aspect of thea pKa of z11 for the protonated form. At pH 7.0, the
average charge on the bis-oxaquinolizidine molecule is interaction with IP3 receptors. Despite the importance
of the cross-sectional area in determining the structure±between 11.5 and 12.0, distributed between the two
tertiary nitrogens. The molecular structures of XeA, XeC, activity relationship, there are clearly other factors con-
tributing to this relationship. For example, the .16-foldand ArB differ only with respect to stereochemistry at
the oxaquinolizidine ring junction and configurations at decrease in potency of DMXeB (relative to XeC) could
be attributed to the fact that the two cis-fused oxaquino-C2,29 and C9,99, the points of attachment of the methy-
lene side chains. Therefore, XeA, XeC, and ArB are dia- lizide rings of DMXeB are more conformationally flexible
stereomers. XeA has the more stable trans ring junction than the mixed junctions of XeC. Further experiments
in both oxaquinolizidine rings and diequatorial substitu- are needed to determine the XeC binding site and refine
ents at C2 and C9, which are disposed trans to each the current model.
other. By contrast, XeC differs from XeA in possessing
the energetically less favorable cis ring junction stereo-
Cytosolic Calcium Measurements in Intactchemistry in one of the oxaquinolizidine rings with di-
PC12 Cells and Astrocytesequatorial substituents at C2 and C9 that are cis to each
Pheochormocytoma (PC12) cells have been shown toother. Clearly the cis, trans orientation of XeC is favored
respond to bradykinin with increased production of IP3for the IP3R since it exhibits a 7-fold higher potency
and transient elevations in cytosolic Ca21 (Fasolato etcompared to XeA. The 2-fold rotationally (C2v) symmetric
al., 1991; Grohovaz et al., 1992). Xe's were shown to beArB (Kitagawa et al., 1989; Hoye et al., 1994, 1995) has
effective IP3R blockers in fura 2±loaded PC12 cells bycis ring fusions and cis C2,9 substituents (axial at C9 to
measuring cytosolic changes in Ca21 following bradyki-the piperidine rings) in both heterobicycles. Unfortu-
nately, interpretations about how the structure of ArB nin addition. Measurements performed in Ca21 replete
Xestospongins: IP3R Channel Blockers
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Figure 3. XeC Blocks Bradykinin Responsiveness of PC12 Cells in Ca21-Depleted Media without Altering the Levels of Ca21 Remaining in the
Stores
Fluorometric measurements in PC12 cells using fura-2 AM (5 mg/ml) and Ca21-depleted media (120 nM and 40 nM Ca21) show that XeC (20
mM) blocks the peak response to bradykinin (300 nM)-induced Ca21 release. In the presence of 40 nM intracellular Ca21, addition of ionomycin
(5 mM) in place of bradykinin shows that Ca21 stores are equal at the time of bradykinin addition. Each trace is a typical response from
triplicate readings. Traces are reported as arbitrary fluorescence units (340 nm/380 nm). The vertical bar represents 1.0 arbitrary fluorescence
ratio units. Column a, [Ca21]e 5 120 nM; column b and c, [Ca21]e 5 40 nM.
medium (2 mM) revealed that a 10 min application of 20 both ryanodine- and IP3-sensitive stores (Zacchettiet al.,
1991). Addition of caffeine (30 mM) to the extracellularmM XeC reduced the peak of the bradykinin (300 nM)-
induced Ca21 transient by 66 6 5% of control (6SD; n 5 medium resulted in a transient rise in intracellular Ca21
(Figure 5A). Pretreatment of cells with 20 mM XeC for4 determinations). Studies using Ca21-depleted media
(120 and 40 nM free Ca21) indicated that addition of 20 10 min prior to addition of caffeine did not significantly
alter the magnitude of the response to the ryanodinemM XeC for 10 min blocked bradykinin-induced Ca21
release in PC12 cells to a similar extent as PC12 cells receptor (RyR) ligand (Figure 5B; Table 1). PC12 cells
also vigorously responded to 50 mM ryanodine with abathed in Ca21 replete buffer (Figure 3). Addition of iono-
mycin (5 mM) in place of bradykinin revealed that treat- sustained rise in cytosolic Ca21 (Figure 5C). Subsequent
addition of bradykinin (100 nM) induced an additionalment of PC12 cells with 20 mM XeC for 10 min did not
significantly affect the level of Ca21 in the stores (Figure but transient rise in cytosolic Ca21. Addition of XeC (20
mM) 10 min prior to ryanodine did not quantitatively alter3). Fluorometric measurements of PC12 cells without
bovine serum albumin (BSA) and/or a lengthened incu- the peak response from the ryanodine-sensitive store
(peak response [6SD] 5 0.16 6 0.03 and 0.18 6 0.02bation time of 30 min revealed that XeC more effectively
targeted the IP3R in the absence of BSA and with ex- ratio units for control and XeC treatment, respectively;
Figure 5D; Table 1). Subsequent addition of bradykinintended incubation times (data not shown). XeC appears
to be maximally effective at blocking bradykinin- produced a negligible response from the IP3-sensitive
store. In PC12 cells, ryanodine (50 mM) induced ER Ca21induced Ca21 release at bath concentrations of XeC as
low as 10 mM, whereas 5 mM XeC results in a bradykinin- release from the same store affected by caffeine, as
demonstrated by the sequential addition of these com-induced Ca21 mobilization, which is comparable to con-
trol levels (Figure 4). Reintroduction of Ca21 to the extra- pounds (Figure 5E). Addition of caffeine followed by
ryanodine also demonstrated a common ryanodine/caf-cellular medium ([Ca21]e 5 2 mM) following bradykinin
stimulation showed that capacitative Ca21 influx is re- feine-sensitive store (data not shown). Taken together,
the results in PC12 cells demonstrate that XeC can dis-duced proportionally in the presence of 10 and 20 mM
XeC (Figure 4). Interestingly, subsequent thapsigargin criminate between ryanodine- and IP3-sensitive Ca21 ef-
flux pathways in intact PC12 cells. PC12 cells acutely(500 nM) addition revealed that the Ca21 leak from the
ER is significantly reduced in the presence of 10 or 20 treated with Xe's displayed no overt signs of cytotoxic-
ity. Application of 20 mM XeC for 30 min did not inducemM XeC (Figure 4).
Experiments aimed at determining whether XeC could trypan blue dye leakage into the cytosol of PC12 cells
(zero cells stained/two dishes [35 mm2]), indicating adiscriminate between IP3- and ryanodine-sensitive stores
were conducted using ratiofluorescence imaging of fura viable cell population.
Xe's were also shown to block muscarinic-mediated2±loaded PC12 cells, a neuronal cell model, which has
Neuron
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theory on capacitative Ca21 entry. A potentially impor-
tant new finding with XeC is the substantial reduction
in the ER Ca21 leak unmasked by thapsigargin, a smooth
ER Ca21 pump inhibitor (Figure 4). The XeC-mediated
reduction in the ER Ca21 leak may be attributed toblock-
ade of the conformationally distinct leak states of the Ry
and/or IP3 receptor. In this respect, ryanodine-sensitive
and insensitive (ªleakº) Ca21 efflux pathways in skeletal
SR (Pessah et al., 1997) and ER Ca21 ªleakageº via the
IP3R in brain (Cameron et al., 1995) have been demon-
strated. Considering the structural and functional simi-
larity of Ry and IP3 receptors, the present results support
a dual role (Ca21 channel and Ca21 leak) for this class
of ER/SR proteins (Cameron et al., 1995; Marks, 1996;
Pessah et al., 1997). Xe's not only represent an optimal
probe to study IP3-mediated signaling processes and
Ca21 dynamics in intact cells, but provide a unique phar-
macological tool to further investigate the structure and
functional properties of isolated IP3-gated channels.
In conclusion, the present paper demonstrates that
Xe's represent a new class of blockers of IP3-induced
Ca21 release from isolated ER membrane vesicles hav-
ing nanomolar to micromolar affinity. The membrane
permeant properties of Xe's also make them very useful
tools for studying IP3-mediated signaling in preparations
of intact cells. Their ability to discriminate between ryan-
Figure 4. XeC Dose Dependently Blocks Bradykinin-Induced Ca21 odine- and IP3-sensitive stores in intact cells provides
Release in PC12 Cells
a distinct advantage to currently available inhibitors.
Fluorometric measurements using fura-2 AM (5 mg/ml) and Ca21- Although the lipophilic elongated hydrocarbon core un-
depleted media (120 nM) show that 20 and 10 mM XeC maximally
doubtedly contributes to the cell permeant propertiesblock the peak response to bradykinin (300 nM)-induced Ca21 re-
of Xe's, it may also promote appreciable partitioninglease, while 5 mM XeC has no significant effect. Following the reintro-
duction of Ca21 ([Ca21]e 5 2 mM), thapsigargin (500 nM) was added of Xe's into cellular membrane lipids. The latter could
to quantitate the ER Ca21 leak. Each trace is a typical response account for the need to use 10±20 mM in the bath to
from duplicate experiments. The vertical bar represents 0.5 arbitrary attain sufficient concentrations of Xe at the ER surface.
fluorescence ratio units. However, the physicochemical properties of XeC, which
requires higher concentrations in cell culture, do not
limit the selectivity of XeC for IP3R over RyR in PC12
IP3-induced Ca21 release in primary astrocytes, follow- cells (Figure 5), nor do they induce acute cytotoxicity.
ing addition of carbachol. Using confocal fluorescent The actual concentrations of XeC reaching the ER sur-
microscopy, XeC (20 mM) was shown to block IP3- face are probably significantly lower than those applied
induced Ca21 release and oscillations in primary to the extracellular medium.
astrocytes (Figures 6A and 6B). In addition, XeA was Xe's can be used to further our understanding of the
shown to block IP3-induced Ca21 release in a concentra- large variety of IP3-mediated signaling pathways cur-
tion-dependent manner, with 20 mM XeA completely rently identified in neuronal and nonneuronal cells. In
blocking Ca21 release and oscillations in most cells (Fig- this respect, previous research has already shown that
ures 6C±6F). Treatment of astrocyte cultures with 20 Xe's disrupt IP3R-mediated cellular processes. Three
mM XeC for 30 min did not cause leakage of lactate Xe's (XeA, XeC, and XeD), originally isolated by Naka-
dehydrogenase (LDH) into the media (untreated 5 3.34 gawa et al. (1984), were identified as vasodilative com-
U/l; treated 5 2.55 U/l). pounds since they increased blood flow in the coronary,
Data provided from PC12 cells and primary astrocytes vertebral, and femoral arteries of anesthetized dogs
demonstrate that Xe's block phosphoinositide signaling (Nakagawa et al., 1984; Endo et al., 1986). Kitagawa et
regardless of the agonist used (bradykinin and carba- al. (1989) subsequently reported the vasodilative prop-
mylcholine, respectively), revealing the general use- erties of XeA when the compound was infused into
fulness of these compounds. Further characterization an isolated mesenteric artery preparation from the
of XeC's effects in PC12 cells provides insight into the Sprague-Dawley rat, corroborating the findings of Naka-
Ca21 dynamics of intact cells. Application of ionomycin gawa et al. XeD and DMXeB have also been shown to
in place of bradykinin shows that blockade of the IP3R display growth-inhibitory activity in tumor cell lines and/
with XeC does not alter Ca21 store levels in PC12 cells or Micrococcus luteus (Quirion et al., 1992; Pettit et al.,
(Figure 3). Reintroduction of Ca21 following bradykinin 1996). XeD and DMXeB were found to inhibit murine
addition shows that blockade of IP3-mediated Ca21 re- leukemia (L1210, ED50 5 0.2, 0.8 mg/ml, respectively)
lease with XeC causes a decrease in Ca21 entry that and human epidermoid carcinoma (KB, ED50 5 2.0, 2.5
is proportional to the reduction in Ca21 release from mg/ml, respectively) cell growth activity (Quirion et al.,
1992). XeD has also shown growth-inhibitory activityintracellular stores (Figure 4), which supports current
Xestospongins: IP3R Channel Blockers
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Figure 5. XeC Discriminates between Ryan-
odine- and IP3-Sensitive Stores in PC12 Cells
Fluorometric measurements using fura-2 AM
(5 mg/ml) and Ca21 (2 mM)-replete media
show that PC12 cells possess ryanodine- and
IP3-sensitive Ca21 stores. Traces under con-
trol were treated with 4 ml MeOH 10 min prior
to caffeine (A) or ryanodine ([C] and [E]) addi-
tion. Traces under XeC were treated with 20
mM XeC (in 4 ml MeOH) 10 min prior to addi-
tion of caffeine (B) or ryanodine (D). The verti-
cal bar represents 0.05 arbitrary fluorescence
ratio units. Table 1 summarizes the peak re-
sponses to RyR ligands in the presence and
absence of XeC.
in a variety of leukemia (CCRF-CEM, HL-60TB, K-562, Micrococcus luteus (12.5±25 mg/6 mm disk) (Pettit et
al., 1996). The vasodilative and growth-inhibitory activityMOLT-4, and SR) and breast tumor (MCF7, HS 578T,
MDA-MB-435, and MDA-N) cell lines (averaged GI50 5 of Xe's are consistent with their newly recognized IP3R
channel-blocking activity, since vasoconstriction and3.62 and 4.53 mM, respectively) and in the bacterium
cell division require IP3-mediated Ca21 release (Berridge,
1993; Briner et al., 1993; Dauphin et al., 1994; Bret-
Table 1. XeC Inhibits IP3-Mediated Ca21 Release without schneider et al., 1995a, 1995b; Sullivan et al., 1995).




Treatment (340/380 6 SD) Materials
D-myo-inositol 1,4,5-trisphosphate and L-myo-inositol 1,4,5-tris-Bradykinin
phosphate were obtained from LC Laboratories (Woburn, MA). So-Control (n 5 10) 0.12 6 0.03
dium heparin (MW 6000) was purchased from Sigma (St. Louis).20 mM XeC (n 5 15) 0.04 6 0.01
[3H]D-myo-inositol 1,4,5-trisphosphate (specific activity, 21 Ci/Caffeine
mmol) and [3H]ryanodine (specific activity, 81.5 Ci/mmol; purity,Control (n 5 18) 0.40 6 0.16
.99%) were obtained from New England Nuclear (Wilmington, DE).20 mM XeC (n 5 20) 0.47 6 0.28
High-purity ryanodine (.99%; used in radioligand receptor bindingRyanodine
assays) and ryanodine mixture (1:3 ryanodine±dehydroryanodine;Control (n 5 10) 0.16 6 0.03
used in whole cell experiments) were purchased from Calbiochem20 mM XeC (n 5 15) 0.18 6 0.02
(San Diego, CA). Bradykinin was obtained from Peptides Interna-
aPeak response is the average maximal change in arbitrary fluores- tional (Louisville, KY) and carbachol from Sigma (St. Louis). All other
cence units (340 nm±380 nm) to addition of 300 nM bradykinin fol- chemicals used were of the highest grade possible.
lowing or 50 mM ryanodine treatment, 30 mM caffeine. The data
represent the mean 6 SD of the number of determinations indicated
Collection of Xe'sin parentheses in column 1. Repesentative traces are shown in
Two samples (A and B) of the marine sponge Xestospongia speciesFigure 5.
(Phylum Porifera) were collected by hand using SCUBA at two sites
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Figure 6. XeC and XeA Effectively Block IP3-
Mediated Ca21 Release and Oscillations in
Primary Astrocytes
Each line indicates the Ca21 concentration
over time in a single cell. Cells were loaded
with indo-1 AM for 30 min prior to experimen-
tation, and fluorescence was monitored using
a scanning confocal fluorescent microscope,
as described in Experimental Procedures.
Carbachol (1 mM) was added 55 s (indicator
line) after a 30 min incubation with control
buffer, XeC, or XeA.
(A) Paired control (XeC).
(B) XeC (20 mM).
(C) Paired control (XeA).
(D) XeA, 1 mM.
(E) XeA, 10 mM.
(F) XeA, 20 mM.
from Exmouth Gulf, Western Australia, in 1993. Whole animals were elution with a stepped gradient of 100:0 chloroform±methanol to
0:100 chloroform±methanol). Final purification of the active fractionsimmediately frozen and stored at 2208C for 2 years. The sponge
was identifiedby MaryKay Harper, Scripps Institution of Oceanogra- was achieved by high-pressure liquid chromatography using two
different conditions and detection by differential refractometry. Thephy (La Jolla, CA). XeA, XeC, and ArB were isolated from Sample
A (collected at a depth of 22 m), and XeD and DMXeB were isolated active fraction from sample A was separated on a normal phase
silica high-pressure liquidchromotography column (RaininDynamaxfrom sample B (collected at 210 m).
Si, 25 3 300 mm, 1:4 hexane: 2-propanol, containing 0.5% tri-
ethylamine, 3 ml/min) to give XeA (0.02% of dry weight) (NakagawaIsolation and Characterization of Xe's
Each sponge sample was processed in a similar manner, and purifi- et al., 1984), XeC (0.03% of dry weight) (Nakagawa et al., 1984), and
ArB (0.017% of dry weight) (Kitagawa et al., 1989; Hoye et al., 1994,cation of active fractions was assessed for their ability to inhibit IP3-
induced Ca21 release from vesicles as described below. Lyophilized 1995). The active fraction from B was purified on an amino-bonded
column (Rainin Dynamax NH2, 25 3 300 mm, 98:2 hexane: 2-propa-sponge tissue was exhaustively extracted with methanol at 258C
(three times), and the combined methanol extract was concentrated nol containing 0.05% triethylamine, 3 ml/min) to provide pure XeD
(0.0089% of dry weight) (Nakagawa et al., 1984) and DMXeBto z500 ml. The methanol extract was adjusted to z10% v/v H2O
and extracted with n-hexane. The aqueous methanol layer was ad- (0.0084% of dry weight) (Quirion et al., 1992). The structures were
identified by comparison of 1H and 13C NMR data of purified com-justed to 20% H2O and extracted with chloroform. Finally, the metha-
nol was removed from the aqueous fraction under reduced pressure, pounds with those of literature values (Nakagawa et al., 1984; Kita-
gawa et al., 1989; Quirion et al., 1992; Hoye et al., 1994, 1995).and the residue was extracted with n-butanol. IP3R inhibitory activity
was located in the chloroform soluble fraction, which was further In order to examine how the three-dimensional molecular struc-
ture of Xe/araguspongine alkaloids might relate to their ability topurified by column chromatography over silica gel (230±400 mesh,
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block the IP3-activated pore, solution structures of XeA, XeC, and acidic protein and neuron-specific enolase (Accurate Chemical,
Westbury, NY).ArB were calculated using force field molecular mechanics (MM2)
(Chem3D Plus, Cambridge Scientific Computing, Cambridge, MA).
The atomic coordinates X-ray crystal structure of XeC (Cambridge Calcium Transport Measurements
Crystallographic Data Center, Cambridge, England) were used as Release of Ca21 from cerebellar and skeletal membrane vesicles
the starting point for MM2 minimization to obtain quantitative struc- was measured with the metallochromic dye antipyrylazo III in a
tural information for XeC. The MM2 structure of XeA was obtained diode array spectrophotometer (model 8542, Hewlett Packard, Palo
by force field minimization of a hybrid set of atomic coordinates for Alto, CA).
XeA. The hybrid data set, in turn, was generated by bond bisection Cerebellar microsomes were batch-loaded with Ca21 overnight
of the dimeric XeC crystal structure, discarding the cis-ring heterobi- (20 hr) at 48C in Ca21 transport buffer (8 mM K-MOPS [pH 7.0], 40
cycle and religating two copies of the trans-monomer. Both struc- mM KCl, 62.5 mM KH2PO4, and 250 mM antipyrylazo III) containing
tures preserve the chair±chair conformations of the oxaquinolizidine 80±160 mg/ml creatine phosphokinase, 20±40 mM phosphocreatine,
ring. Distance-dependent dielectric factors were not used in the 4±8 mM Mg±ATP, 4 mM NaN3, 40 mg/ml leupeptin, 100 mM CaCl2,
calculations, and the minimized structures do not take into account and 333±667 mg/ml cerebellar microsomal protein. Calcium-loaded
possible water of solvation. microsomes were then diluted 1:3 in Ca21 transport buffer lacking
microsomes (final volume 1.2 ml). Upon warming the solution to
378C (500 s), the ability of Xe's/araguspongines to block IP3 (5 mM)-Membrane Preparations induced Ca21 release was assessed in temperature-controlled cu-
Microsomes enriched with the IP3R were isolated from the cerebel- vettes with constant stirring.
lum of 2.5±3 kg male New Zealand white rabbits. Tissue was homog- Skeletal vesicles (50 mg protein/cuvette) were loaded with Ca21
enized with a Potter-Elvehjem homogenizer in 103 (w/v) ice-cold in Ca21 transport buffer containing 18.5 mM K-MOPS (pH 7.0), 92.5
buffer containing 5 mM HEPES (pH 7.4), 320 mM sucrose, 250 mM mM KCl, 7.5 mM sodium pyrophosphate, 250 mM antipyrylazo III, 1
phenylmethylsulfonyl fluoride, and 5 mg/ml leupeptin. Microsomes mM Mg±ATP, 20 mg/ml creatine phosphokinase, and 5 mM phos-
were subsequently isolated by differential centrifugation (8,000± phocreatine, with a final volume of 1.2 ml. Immediately prior to
100,000 3 g pellet). The final microsomal pellet was resuspended measuring caffeine-induced Ca21 release, vesicles were loaded to
with a Dounce homogenizer in buffer lacking protease inhibitors at near capacity with serial additions of 24 nmol CaCl2 in temperature-a protein concentration of 5±10 mg/ml. Microsomes were aliquoted controlled cuvettes (378C) with constant stirring. The ability of XeC
into vials, quickly frozen in liquid nitrogen, and stored at 2808C. (0.1±10 mM) to block caffeine (20 mM)-induced Ca21 release via Ry1RMembrane vesicles enriched in Ry1R were isolated from the fast- was determined after the dye signal returned to baseline following
twitch (white) skeletal muscle of the hind limbs and back of 3±4 loading.
kg male New Zealand white rabbits. Freshly ground muscle was Calcium transport was measured using a multisample transporter
homogenized in a Waring blender with 4 v of ice-cold homogeni- to sequentially measure two samples. Changes in extravesicular
zation buffer composed of 5 mM imidazole±HCl (pH 7.4), 0.3 M free Ca21 were determined by subtracting the antipyrylazo III ab-
sucrose, 10 mg/ml leupeptin, and 100 mM phenylmethylsulfonyl fluo- sorbance at 790 nm from the absorbance at 710 nm. For each curve,
ride. The junctional SR fraction was purified from a discontinuous methanol controls were acquired simultaneously to normalize the
sucrose gradient as previously described by Saito et al. (1984). The degree of inhibition found in the samples containing Xe. In each
junctional SR fraction was collected from the 38%±45% sucrose experiment, absorbance signals were calibrated by the addition of
interface, pelleted, and then resuspended in ice-cold homogeniza- 1.0 mg of the Ca21 ionophore, A23187, followed by 20 or 24 nmol
tion buffer at a protein concentration of 3±5 mg/ml. Membranes additions of CaCl2 from a National Bureau of Standards stock solu-were aliquoted intovials, quickly frozen in liquid nitrogen, and stored tion. Initial Ca21 release rates were determined by linear regression
at 2808C. Protein concentrations were determined using the Lowry analysis of the first 15±50 s of Ca21 release.
method (Lowry et al., 1951), with BSA as the standard.
[3H]IP3 Binding Assay
Specific binding of [3H]IP3 to cerebellar microsomes was determinedCell Culture
according the methods of Mohr et al. (1993) with minor modifica-PC12 cells were obtained from American Type Culture Collection
tions. The ability of XeC to block the binding of 1 nM [3H]IP3 to(Rockville, MD) and cultured at 378C, 5% CO2 in RPMI 1640 media
high-affinity sites on cerebellar microsomes (200 mg protein) dosesupplemented with 2.05 mM L-glutamine, 10% heat-inactivated
dependently was assayed in a buffer containing 100 mM KCl, 20horse serum (at 568C for 30 min), 5% fetal bovine serum, 100 U/ml
mM NaCl, 1 mM EDTA, 0.1% BSA, and 25 mM Na2HPO4 (pH 8.0).penicillin, and 100 mg/ml streptomycin on 75 cm2 Primaria tissue
XeC (1±10 mM) was added to cerebellar microsomes, andthe bindingculture flasks (Falcon 3824, Becton Dickinson, Lincoln Park, NJ).
reaction was initiated with addition of [3H]IP3 assay buffer (1 ml finalMedia was changed every 2 days, and cells were passaged bi-
volume). Tubes were incubated at 48C with constant shaking. Afterweekly. PC12 cells were plated on laminin-coated glass rectangular
30 min, assays were terminated by rapid, single manifold filtration(9 3 22 cm) or round (d 5 2.5 cm) coverslips at a density of 1 3
through Whatman GF/B filters presoaked with ice-cold assay buffer,105 cells/cm2. Cells wereused for experiments 2±3 days after plating.
followed by immediate washing of filters with 2.5 ml ice-cold assayPrimary rat cortical astrocyte cultures were prepared by a modifi-
buffer. Filters were soaked overnight in 5 ml scintillation cocktail,cation of the method of McCarthy and De Vellis (1980), as described
and the radioactivity on the filters was measured using a liquidpreviously (Guizzetti et al., 1996). Briefly, the cortices from day 21
scintillation counter. Nonspecific binding was measured in the pres-fetuses (B&K Universal, Kent, WA) were minced, trypsinized, and
ence of a 500-fold excess of unlabeled IP3.washed three times by centrifugation with Dulbecco's Modified Ea-
gle Medium supplemented with 10% fetal bovine serum. The tissue
was triturated, filtered, and platedin 75 cm2 flasks, previously coated [3H]Ryanodine Binding Assay
Specific binding of [3H]ryanodine to skeletal membrane vesicles waswith poly-d-lysine, at 1.5 3 105 cells/cm2. Within 24 hr of plating,
the flasks were shaken, and fresh media was added. Flasks were determined according to the methods of Pessah et al. (1987). The
ability of XeC to dose dependently block the binding of 1 nM [3H]ry-maintained at 378C with 5% CO2 for 9 days and fed every 3±4 days.
On day 9 in culture, the flasks were shaken overnight, trypsinized, anodine to high-affinity sites on skeletal SR (50 mg protein) was
assayed in a buffer consisting of 20 mM HEPES (pH 7.1), 250 mMand reseeded in two-well cover glass chamber slides (Nunc 178656,
Intermountain Scientific, Bountiful, UT), previously coated with poly- KCl, 15 mM NaCl, 10% sucrose, and 50 mM CaCl2. XeC (0.1±10 mM)
was added to skeletal microsomes, and the binding reaction wasd-lysine, at 2.4 3 105 cells/cm2. Following reseeding, astrocytes
were grown for 2 days, then rinsed with phosphate-buffered saline, initiated with addition of [3H]ryanodine assay buffer (500 ml final
volume). Following incubation for 3 hr at 378C, assays were termi-and serum-deprived for 2 days in Dulbecco's Modified Eagle Me-
dium supplemented with 0.1% Fraction V fatty acid±free BSA. nated by rapid filtration, with a Brandel (Gaithersburg, MD) cell har-
vester, through Whatman GF/B glass fiber filters. Filters were rinsedAstrocyte cultures were determined to be at least 95% pure by
indirect immunofluorescence with antibodies against glial fibrillary three times with 2 ml ice-cold harvest buffer (20 mM Tris±HCl [pH
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7.1], 250 mM KCl, 15 mM NaCl, and 50 mM CaCl2) and soaked lactate-dehydrogenase EC 1.1.1.27 UV-test kit (catalog No.
DG1340-K).overnight in 5 ml scintillation cocktail. Radioactivity on the filters
was measured with a liquidscintillation counter.Nonspecific binding
of [3H]ryanodine was determined by the addition of 1000-fold excess
Acknowledgmentsof cold ryanodine.
The authors would like to thank Helen Kim for her assistance inFluorometric Measurements of Cytosolic
the transport assays and Tom Chavez for his contribution to theCalcium in Intact Cells
ryanodine binding studies. We thank Marilyn Olmstead for assis-Two to three days following plating, intracellular Ca21 was measured
tance with conversion of the fraction crystal coordinates of XeC.from PC12 cellpopulations either using a fluorometer (model F-2000,
This work was supported by National Institutes of Health TrainingHitachi, Japan) or ratiofluorescence video imaging (Photon Technol-
Grant ES07059 (J. G.), RO1 ES05002 (I. N. P.), RO1 AI39987 andogy International, Princeton, NJ). Cells were loaded with a 5 mg/ml
RO1 AI31660 (T. F. M.), RO1 AA08154 and P30 ES07033 (L. G. C.),solution of cell permeant fura-2 acetoxymethyl ester (fura-2 AM,
and by a Grant-in-Aid of Research from the National Academy ofMolecular Probes, Eugene, OR) in imaging buffer (125 mM NaCl, 5
Sciences through Sigma Xi, The Scientific Research SocietymM KCl, 2 mM KH2PO4, 1.2 mM MgSO4, 2 mM CaCl2, 25 mM HEPES,
(J. A. M.).6 mM glucose, 0.05% BSA [fraction 5], and 250 mM sulfinpyrazone
[pH 7.4]) for 30 min at 258C. PC12 cells were then rinsed twice and
stored in imaging buffer until needed (0 or 30 min). Coverslips were Received April 4, 1997; revised July 14, 1997.
left to equilibrate for 2±3 min in imaging buffer before measurements
began. In initial experiments, MeOH (10 ml) or Xe's (20 mM) were
added 2 min after recording began, and bradykinin (300 nM) or References
ionomycin (5 mM) was added 10 min later. Measurements performed
in Ca21-depletedmedia were made by addition of EGTA (3 and 5 mM Arrang, J.M. (1994). Pharmacological properties of histamine recep-
final concentrations) 1 min prior to bradykinin/ionomycin addition, tor subtypes. Cell. Mol. Biol. 40, 275±281.
to obtain free Ca21 levels of 120 and 40 nM, respectively. In the
Berridge, M.J. (1993). Inositol trisphosphate and calcium signaling.
experiments examining the XeC dose±response relationship and
Nature 361, 315±325.
effect of Xe's on the RyR, PC12 cells were incubated with MeOH
Bezprozvanny, I.B., Ondrias K., Kaftan E., Stoyanovsky D.A., and(4 or 10 ml) or XeC (5±20 mM) for 30 min and 20 min, respectively,
Ehrlich, B.E. (1993). Activation of the calcium release channel (ryan-in buffer lacking 0.05% BSA, before bradykinin addition. Measure-
odine receptor) by heparin and other polyanions is calcium depen-ments were performed at a constant 378C in continually stirred cu-
dent. Mol. Biol. Cell 4, 347±352.vettes (photometry) or a clamp chamber (imaging). The arbitrary
Brann, M.R., Klimkowski, V.J., and Ellis, J. (1993). Structure/functionfluorescence units of 340 nm/380 nm were used to compare the
relationships of muscarinic acetylcholine receptors. Life Sci. 52,Xe-treated and control cell populations.
405±412.Calcium measurements on primary rat cortical astrocyte cultures
were carried out by a modification of the method of Kovacs et al. Bretschneider, E., Paintz, M., and Glusa, E. (1995a). Inositol 1, 4, 5-
(1995). At the time of the experiment, media was removed, and cells trisphosphate and protein kinase C are involved in thrombin- and
were rinsed twice with Krebs bicarbonate buffer and loaded with a trap-induced vascular smooth muscle contraction. Agents Actions
2 mM solution of cell permeant indo-1 acetoxymethyl ester (indo-1 Suppl. 45, 309±313.
AM, Molecular Probes, Eugene, OR) in Krebs buffer, containing 1% Bretschneider, E., Paintz, M., and Glusa, E. (1995b). Involvement of
Fraction V BSA, 0.001% lipids-cholesterol-rich solution, and 1 mM inositol 1, 4, 5-trisphosphate and protein kinase C in thrombin-
probenecid, for 30 min at 378C. Following loading, cells were rinsed induced contraction of porcine ulmonary artery. Biochem. Pharma-
with Krebs buffer, without BSA and lipids, and incubated for at least col. 49, 33±38.
15 min at 378C to allow for cleavage of the indo-1 AM ester. Indo-1
Briner, V.A., Tsai, P., and Schrier, R.W. (1993). Bradykinin: potentialwas excited at 351±363 nm, and emission was detected simultane-
for vascular constriction in the presence of endothelial injury. Am.ously at 405 and 530 nm to measure the fluorescence intensity of
J. Physiol. 264, F322±F327.the dye bound and not bound to Ca21, respectively. Fluorescence
Cameron, A.M., Steiner, J.P., Sabatini, D.M., Kaplin, A.I., Walensky,measurements were made using an attached-cell analysis and
L.D., and Snyder, S.H. (1995). Immunophilin FK506-binding proteinsorter Ultima instrument (Meridian Instruments, Okemos, MI). The
associated with inositol 1,4,5-trisphosphate receptor modulates cal-ratio of the fluorescence at the two wavelengths was determined and
cium flux. Proc. Natl. Acad. Sci. USA 92, 1784±1788.was compared to the ratio for Ca21 standard in solution (Molecular
Probes, Eugene, OR) to determine the absolute Ca21 concentration. Crews, P., Slate, D.L., Gerwick, W.H., Schmitz, F.J., Scatzman, R.,
The fluorescence within 50 cells was quantified over time for each Strulovici, B., Cannon, P., and Hunter, L.M. (1994). Screening for
treatment. For Xe experiments, cells were preincubated with the anticancer leads from marine organisms ina mechanism-based drug
inhibitor for 30 min. Prior to carbachol addition, baseline Ca21 mea- delivery program. Dev. Oncol. 74, 364±403.
surements were determined by three scans conducted at 15 s inter- Dauphin, F., Linville, D.G., and Hamel, E. (1994). Cholinergic dilata-
vals. After the third scan, a 30 s lapse in scanning allowed for the tion and constriction of feline cerebral blood vessels are mediated
addition of carbachol (1 mM), and then Ca21 changes were moni- by stimulation of phosphoinositide metabolism via two different
tored every 15 s for 17 scans. muscarinic receptor subtypes. J. Neurochem. 63, 544±551.
Endo, M., Nakagawa, M., Hamamoto, Y., and Ishihama, M. (1986).
Measurements of Acute Cytotoxicity Pharmacologically active substances from southern Pacific marine
In order to assess the acute toxicity of Xe's, trypan blue staining invertebrates. Pure Appl. Chem. 58, 387±394.
and LDH measurements were performed on PC12 cells and primary
Fasolato, C., Zottini, M., Clementi, E., Zacchetti, D., Meldolesi, J.,astrocyte cultures, respectively. Two days after plating, 4 ml MeOH
and Pozzan, T. (1991). Intracellular Ca21 pools in PC12 cells. J. Biol.or 20 mM XeC was added to PC12 cells, and cells were left to
Chem. 266, 20159±20167.incubate at 378C, 5% CO2 for 10 or 30 min. Following incubation,
Furuichi, T., Yoshikawa, S., Miyawaki, A., Wada, K., Maeda, N., andmedia was removed, 0.4% trypan blue in culture media (1:3 v/v)
Mikoshiba, K. (1989). Primary structure and functional expressionwas added, and 10 fields of view (1003) were assessed for the
of the inositol 1,4,5-trisphosphate-binding protein P400. Nature 342,presence of dead cells. Triton X-100 (0.1%)-treated cells were used
32±38.as a positive control. In astrocyte cultures, the levels of LDH in
the media were measured following treatment of cells with 20 mM Ghosh, T.K., Eis, P.S., Mullaney, J.M., Ebert, C.L., and Gill, D.L.
(1988). Competitive, reversible, and potent antagonism of inositolXeC for 30 min. Incubation for 30 min with buffer alone or a cytotoxic
concentration of Triton X-100 (0.1%) were used as controls. LDH 1,4,5-trisphosphate-activated calcium release by heparin. J. Biol.
Chem. 263, 11075±11079.levels were measured using the Sigma Diagnostics LDH optimized
Xestospongins: IP3R Channel Blockers
733
Grohovaz, F., Zacchetti, D., D'Andrea, P., Lorenzon, P., and Mel- P.D., Mohr, F.C., and Mack, M.M. (1997). Bastadinsrelate ryanodine-
sensitive and -insensitive Ca21 efflux pathways in skeletal SR anddolesi, J. (1992). [Ca21]i effects of bradykinin B2 receptor activation
in PC12 cells. Agents Actions. Suppl. 38, 9±15. BC3H1 cells. Am. J. Physiol. 272, C601±C614.
Pettit, G.R., Orr, B., Herald, D.L., Doubek, D.L., Tackett, L., Schmidt,Guizzetti, M., Costa, M., Peters, J., and Costa, L.G. (1996). Acetyl-
choline as a mitogen: muscarinic receptor-mediated proliferation of J.M., Boyd, M.R., Pettit, R.K., and Hooper, J.N.A. (1996). Isolation
and x-ray crystal structure of racemic xestospongin D from therat astrocytes and human astrocytoma cells. Eur. J. Pharmacol. 297,
265±273. Singapore marine sponge Niphates sp. Bioorg. Med. Chem. Lett. 6,
1313±1318.Harnick, D.J., Jayaraman, T., Ma, Y., Mulieri, P., Go, L.O., and Marks,
A.R. (1995). The human type 1 inositol 1,4,5-trisphosphate receptor Pin, J.-P., and Duvoisin, R. (1995). Review: neurotransmitter recep-
tors I±the metabotropic glutamate receptors: structure and func-from T lymphocytes. Structure, localization, and tyrosine phosphor-
ylation. J. Biol. Chem. 270, 2833±2840. tions. Neuropharmacology 34, 1±26.
Quirion, J.C., Sevenet, T., Husson, H.P., Weniger, B., and Debitus, C.Hoye, T.R., North, J.T., and Yao, L.J. (1994). Conformational consid-
erations in 1-oxaquinolizidines related to the xestospongin/aragu- (1992). Two new alkaloids from Xestospongia sp., a new Caledonian
sponge. J. Nat. Prod. 55, 1505±1508.spongine family: reassignment of stereostructures for araguspon-
gines B and E. J. Org. Chem. 59, 6904±6910. Ross, C.A., Danoff, S.K., Schell, M.J., Snyder, S.H., and Ullrich,
A. (1992). Three additional inositol 1,4,5-trisphosphate receptors:Hoye, T.R., North, J.T., and Yao, L.J. (1995). Conformational consid-
erations in 1-oxaquinolizidines related to the xestospongin/aragu- molecular cloning and differential localization in brain and peripheral
tissues. Proc. Natl. Acad. Sci. USA 89, 4265±4269.spongine family: reassignment of stereostructures for araguspon-
gines B and E. J. Org. Chem. 60, 4958. Saito, A., Seiler, S., Chu, A., and Fleischer, S. (1984). Preparation
and morphology of sarcoplasmic reticulum terminal cisternae fromKitagawa, I., Kobayashi, M., and Kawazoe, K. (1989). Araguspon-
gines B, C, D, E, F, G, H, and J, new vasodilative bis-1-oxaquinolizi- rabbit skeletal muscle. J. Cell Biol. 99, 875±885.
dine alkaloids from an okinawan marine sponge, Xestospongia sp. SuÈ dhof, T.C., Newton, C.L., Archer, B.T.d., Ushkaryov, Y.A., and
Chem. Pharm. Bull. (Tokyo) 37, 1676±1678. Mignery, G.A. (1991). Structure of a novel InsP3 receptor. EMBO J.
10, 3199±3206.Kobayashi, S., Somlyo, A.V., and Somlyo, A.P. (1988). Heparin inhib-
its the inositol 1,4,5-trisphosphate-dependent, but not the indepen- Sullivan, K.M., Lin, D.D., Agnew, W., and Wilson, K.L. (1995). Inhibi-
dent, calcium release induced by guanine nucleotide in vascular tion of nuclear vesicle fusion by antibodies that block activation of
smooth muscle. Biochem. Biophys. Res. Commun. 153, 625±631. inositol 1,4,5-trisphosphate receptors. Proc. Natl. Acad. Sci. USA
92, 8611±8615.Kovacs, K.A., Kavanagh,T.J., and Costa, L.G. (1995). Ethanol inhibits
muscarinic receptor-stimulated phosphoinositide metabolism and Takeshima, H., Nishimura, S., Matsumoto, T., Ishida, H., Kangawa,
calcium mobilization in rat primary cortical cultures. Neurochem. K., Minamino, N., Matsuo, H., Ueda, M., Hanaoka, M., Hirose, T., et
Res. 20, 939±949. al. (1989). Primary structure and expression from complementary
DNA of skeletal muscle ryanodine receptor. Nature 339, 439±445.Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951).
Protein measurement with folin phenol reagent. J. Biol. Chem. 193, Tinker, A., and Williams, A.J. (1995). Measuring the length of the
265±275. pore of the sheep cardiac reticulum calcium-release channel using
related molecular calipers. Biophys. J. 68, 111±120.Maranto, A.R. (1994). Primary structure, ligand binding, and localiza-
tion of the human type 3 inositol 1,4,5-trisphosphate receptor ex- Verma, A., Ross, C.A., Verma, D., Supattapone, S., and Snyder, S.H.
pressed in intestinal epithelium. J. Biol. Chem. 269, 1222±1230. (1990). Rat brain endoplasmic reticulum calcium pools are function-
ally segregated. Cell Regul. 1, 781±790.Marks, A.R. (1996). Cellular functions of immunophilins. Physiol.
Rev. 76, 631±649. Yamada, N., Makino, Y., Clark, R.A., Pearson, D.W., Mattei, M.G.,
Guenet, J.L., Ohama, E., Fujino, I., Miyawaki, A., Furuichi, T., et al.McCarthy, K.D., and De Vellis, J. (1980). Preparation of separate
astroglial and oligodendroglial cell cultures from rat cerebral tissue. (1994). Human inositol 1,4,5-trisphosphate type-1 receptor, insP3R1:
structure, function, regulation of expression and chromosomal lo-J. Biol. Chem. 85, 890±902.
calization. Biochem. J. 302, 781±790.Mignery, G.A., SuÈ dhof, T.C., Takei, K., and De Camilli, P. (1989).
Putative receptor for inositol 1,4,5-trisphosphate similar to ryano- Zacchetti, D., Clementi, E., Fasolato, C., Lorenzon, P., Zottini, M.,
Grohovoz, F., Fumagalli, G., Pozzan, T., and Meldolesi, J. (1991).dine receptor. Nature 342, 192±195.
Intracellular Ca21 pools in PC12 cells. J. Biol. Chem. 266, 20152±Mignery, G.A., Newton, C.L., Archer, B.T.d., and SuÈ dhof, T.C. (1990).
20158.Structure and expression of the rat inositol 1,4,5-trisphosphate re-
ceptor. J. Biol. Chem. 265, 12679±12685.
Mohr, F.C., Hershey, P.E., Zimanyi, I., and Pessah, I.N. (1993). Regu-
lation of inositol 1,4,5-trisphosphate receptors in rat basophilic leu-
kemia cells. I. Multiple conformational states of the receptor in a
microsomal preparation. Biochem. Biophys. Acta 1147, 105±114.
Nakade, S., Maeda, N., and Mikoshiba, K. (1991). Involvement of
the C-terminus of the inositol 1,4,5-trisphosphate receptor in Ca21
release analysed using region-specific monoclonal antibodies. Bio-
chem. J. 277, 125±131.
Nakagawa, M., Endo, M., Tanaka, N., and Gen-Pei, L. (1984). Struc-
tures of xestospongin A, B, C and D, novel vasodilative compounds
from marine sponge, Xestospongia exigua. Tetrahedron Lett. 25,
3227±3230.
Nakanishi, S., Maeda, N., and Mikoshiba, K. (1991). Immunohisto-
chemical localization of an inositol 1,4,5-trisphosphate receptor,
P400, in neural tissue: studies in developing and adult mouse brain.
J. Neurosci. 11, 2075±2086.
Pessah, I.N., Stambuk, R.A., and Casida, J.E. (1987). Ca21-activated
ryanodine binding: mechanisms of sensitivity and intensity modula-
tion by Mg21, caffeine, and adenine nucleotides. Mol. Pharmacol.
31, 232±238.
Pessah, I.N., Molinski, T.F., Meloy, T.D., Wong, P., Buck, E.D., Allen,
